Seegnal Successfully Initiates First U.S. Pilot Program

Executive Summary

• Seegnal Inc. has successfully initiated its first U.S. pilot program with a long-term care provider, following a letter of intent announced on May 19, 2026.
• The pilot is scheduled to run for 8 to 12 weeks from data receipt, with a potential extended evaluation period to follow.
• The initiative targets the ~1.2 million Americans residing in CMS-certified nursing facilities to mitigate adverse drug events and polypharmacy using the company's SaaS-based clinical decision support platform.

Key Details

• Pilot Structure & Timeline: 8–12 week duration from receipt of data, followed by a potential extended evaluation period.
• Target Population: ~1.2 million Americans in CMS-certified nursing facilities, characterized by advanced age, multiple chronic conditions, and high rates of polypharmacy.
• Clinical Problem Addressed: Adverse drug events are a significant preventable cause of hospitalization, accounting for an estimated 99,628 emergency hospitalizations annually in U.S. adults aged 65 and older.
• Technology Deployment: Seegnal’s SaaS clinical decision support platform integrates patient-specific data (medications, lab results, renal function, allergies, age, and risk factors) directly into clinical workflows to reduce alert fatigue and support safer, more precise prescribing.
• Commercial Context: Marks the first U.S. pilot following a letter of intent dated May 19, 2026, serving as a foundational step in the company’s U.S. commercial expansion strategy.
• Current Adoption: The platform is already deployed across healthcare settings and utilized by over 15,000 clinicians in daily practice.

Notable Quotes

• “Initiating this pilot is an important step in executing on our U.S. commercial strategy," said Elad Bibi-Aviv, Chief Executive Officer of Seegnal. “Long-term care is a setting where medication complexity, polypharmacy, and the need for individualized prescribing decisions converge. These are areas where our platform was designed to add value.” “We look forward to working with our pilot partner and to reporting on progress in due course.”